Correlation Between Veracyte and Humacyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Veracyte and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Humacyte, you can compare the effects of market volatilities on Veracyte and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Humacyte.

Diversification Opportunities for Veracyte and Humacyte

-0.6
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Veracyte and Humacyte is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Veracyte i.e., Veracyte and Humacyte go up and down completely randomly.

Pair Corralation between Veracyte and Humacyte

Given the investment horizon of 90 days Veracyte is expected to generate 0.69 times more return on investment than Humacyte. However, Veracyte is 1.45 times less risky than Humacyte. It trades about 0.34 of its potential returns per unit of risk. Humacyte is currently generating about -0.17 per unit of risk. If you would invest  3,412  in Veracyte on August 29, 2024 and sell it today you would earn a total of  872.00  from holding Veracyte or generate 25.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Veracyte  vs.  Humacyte

 Performance 
       Timeline  
Veracyte 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.
Humacyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Humacyte has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Veracyte and Humacyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Veracyte and Humacyte

The main advantage of trading using opposite Veracyte and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.
The idea behind Veracyte and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.